Ilex Medical Ltd markets, sells, and supports equipment, disposables, and reagents for laboratories and healthcare companies in Israel and South Africa. The company offers in vitro diagnostic equipment and reagent systems to hospitals, clinics, and other medical institutions; molecular biology products for cancer screening, retro virus viral load, TB, STDs, and other infectious diseases; and equipment, disposables, and reagents for in vitro fertilization, as well as food and pharma industries. It also distributes and supports nucleic acid testing blood screening solutions to large-scale blood banks; provides pre/post analytics and robotics; and develops, markets, implements, and supports advanced laboratory information systems. In addition, the company offers specialized product range that includes molecular diagnostics, critical care, and immunology products, as well as tailor made laboratory information solutions. Ilex Medical Ltd was founded in 1977 and is based in Petah Tikva, Israel.
Stock data | 2024 | Change |
---|---|---|
Price | $17.14 | N/A |
Market Cap | $191.80M | N/A |
Shares Outstanding | 11.19M | N/A |
Employees | 255.00 | N/A |